KalVista Pharmaceuticals
KALV
#7066
Rank
S$0.55 B
Marketcap
$11.32
Share price
3.34%
Change (1 day)
-26.84%
Change (1 year)

EPS for KalVista Pharmaceuticals (KALV)

EPS in 2023 (TTM): -$4.27

According to KalVista Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$4.28. In 2022 the company made an earnings per share (EPS) of -$5.06 a decrease over its 2021 EPS that were of -$3.62.

EPS history for KalVista Pharmaceuticals from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.27-15.7%
2022-$5.0640.07%
2021-$3.6228.37%
2020-$2.8241.5%
2019-$1.9918.55%
2018-$1.68-49.8%
2017-$3.35
2015-$20.48-6.99%
2014-$22.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.95-31.01%๐Ÿ‡บ๐Ÿ‡ธ USA